Chemotherapy and intensity-modulated radiation therapy for locally advanced pancreatic cancer achieves a high rate of R0 resection.

Published

Journal Article

To assess local control, survival and conversion to resectability among locally advanced pancreatic cancer (LAPC) patients treated with induction chemotherapy (ICT) followed by chemoradiotherapy treatment using intensity-modulated radiation therapy (IMRT).Between 2007 and 2012, 134 LAPC patients were treated with ICT followed by IMRT. After chemoradiotherapy, 40 patients received maintenance chemotherapy.With a median follow-up of 20 months, median overall survival (OS) was 23 months. One- and two-year OS was 85% and 47%, respectively. On multivariate analysis, progression of disease after IMRT was associated with worse OS. Cumulative incidence of local failure was 10% at one year and 36% at two years. Twenty-six patients (19%) underwent resection after chemoradiotherapy including 22 patients (85%) with negative margins. On multivariate analysis, response to IMRT was associated with surgery (p = .01). Acute grade 3-4 hematologic and non-hematologic toxicity rates were 26% and 4.5%, respectively.IMRT is safe in patients with LAPC. Patients with non-progressive LAPC after ICT and who received IMRT had high rates of local control and prolonged survival.

Full Text

Duke Authors

Cited Authors

  • Huguet, F; Hajj, C; Winston, CB; Shi, W; Zhang, Z; Wu, AJ; O'Reilly, EM; Reidy, DL; Allen, P; Goodman, KA

Published Date

  • March 2017

Published In

Volume / Issue

  • 56 / 3

Start / End Page

  • 384 - 390

PubMed ID

  • 27796165

Pubmed Central ID

  • 27796165

Electronic International Standard Serial Number (EISSN)

  • 1651-226X

International Standard Serial Number (ISSN)

  • 0284-186X

Digital Object Identifier (DOI)

  • 10.1080/0284186X.2016.1245862

Language

  • eng